PF-06447475 5 mg | 99.62%
TargetMol
PF-06447475 is a highly effective, specific, brain penetrant LRRK2 inhibitor with IC0 of 3/11 nM for wild type LRRK2 and G2019S LRRK2 respectively.
More Information Supplier PagePF-06447475
Search Results
WHI-P258 100 mg | 99.59%
TargetMol
WHI-P258 is a dimethoxyquinazoline inhibitor of JAK3. This compound binds JAK3 weakly and may be used as a JAK-binding negative control in the development of new therapeutics.
More Information Supplier PageWHI-P258
U-104 200 mg | 100.00%
TargetMol
U-104 (NSC-213841) is an effective carbonic anhydrase (CA) inhibitor for CA IX( Ki=45.1 nM) and CA XII(Ki=4.5 nM).
More Information Supplier PageU-104
U-104 100 mg | 100.00%
TargetMol
U-104 (NSC-213841) is an effective carbonic anhydrase (CA) inhibitor for CA IX( Ki=45.1 nM) and CA XII(Ki=4.5 nM).
More Information Supplier PageU-104
A 77-01 2 mg | 99.31%
TargetMol
A 77-01 is a potent inhibitor of TGF-(beta) type I receptor superfamily activin-like kinase ALK5 with IC50 of 25 nM.
More Information Supplier PageA 77-01
A 77-01 5 mg | 99.31%
TargetMol
A 77-01 is a potent inhibitor of TGF-(beta) type I receptor superfamily activin-like kinase ALK5 with IC50 of 25 nM.
More Information Supplier PageA 77-01
FPH2 100 mg | 99.61%
TargetMol
FPH2 (BRD-9424) is a small molecule promoting differentiation of iPS-derived hepatocytes.
More Information Supplier PageFPH2
SantacruzaMate A 25 mg | 99.55%
TargetMol
Santacruzamate A (CAY10683) is a potent and selective HDAC inhibitor.
More Information Supplier PageSantacruzaMate A
AdipoRon 200 mg | 99.63%
TargetMol
AdipoRon is an orally bioavailable adiponectin receptor agonist. It can combine with AdipoR1/2 (KD: 1.8/3.1 μM).
More Information Supplier PageAdipoRon
AdipoRon 100 mg | 99.63%
TargetMol
AdipoRon is an orally bioavailable adiponectin receptor agonist. It can combine with AdipoR1/2 (KD: 1.8/3.1 μM).
More Information Supplier PageAdipoRon